ALK-Abello A/S (AKBLF)
36.14
0.00 (0.00%)
USD |
OTCM |
Dec 11, 16:00
ALK-Abello EPS Diluted (Quarterly): 0.2219 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.7044 |
| Genmab A/S | 0.6431 |
| Ascendis Pharma A/S | -1.173 |
| Evaxion AS | -0.2862 |
| IO Biotech, Inc. | -0.1252 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 49.16M |
| Revenue (Quarterly) | 239.55M |
| Total Expenses (Quarterly) | 190.39M |
| Enterprise Value | 7.976B |
| Gross Profit Margin (Quarterly) | 68.17% |
| Profit Margin (Quarterly) | 20.52% |
| Earnings Yield | 2.04% |
| Operating Earnings Yield | 2.73% |
| Normalized Earnings Yield | 2.040 |